IBT welcomes new Business Analyst

September 2, 2016

IBT welcomes Crescent Yingyue Liao as Business Analyst.

Crescent holds a Bachelor’s degree in Biochemistry and a Master’s degree in Bioentrepreneurship.

Latest press releases

2026-04-02 09:15 Correction: Notice of Annual General Meeting of Infant Bacterial Therapeutics Regulatory

2026-03-30 14:30 Notice of Annual General Meeting of Infant Bacterial Therapeutics Regulatory

2026-03-27 07:30 Infant Bacterial Therapeutics AB publishes the Annual Report for 2025 Regulatory

2026-03-03 07:00 Infant Bacterial Therapeutics (IBT) publishes results from ”The Connection Study” in Pediatric Research

2026-02-06 07:30 Infant Bacterial Therapeutics AB (publ) Year-end-report January 1 – December 31, 2025 Regulatory

News